Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: A pilot surveillance study

Journal of Clinical Microbiology

Volumn 43, Issue 4, 2005, Pages 1640-1645

  Kasahara, Kei ^a   Maeda, Koichi ^a   Mikasa, Keiichi ^a   Uno, Kenji ^a   Takahashi, Ken ^a   Konishi, Mitsuru ^a   Yoshimoto, Eiichiro ^a   Murakawa, Koichi ^a   Kita, Eiji ^a   Kimura, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFDITOREN; CEFEPIME; CEFOTAXIME; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MEROPENEM; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; ERMB GENE; GENE ISOLATION; JAPAN; MEFA GENE; MEFE GENE; MOLECULAR CLONING; NONHUMAN; PENICILLIN RESISTANCE; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; HUMANS; JAPAN; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PILOT PROJECTS; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

EID: 20144386881     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.4.1640-1645.2005     Document Type: Article

References (35)

1. Appelbaum, P. C. 1987. World-wide development of antibiotic resistance in pneumococci. Eur. J. Clin. Microbiol. 6:367-377.
2. Beall, B., M. C. McEllistrem, R. E. Gertz, Jr., D. J. Boxrud, J. M. Besser, L. H. Harrison, J. H. Jorgenson, C. G. Whitney, and the Active Bacterial Core Surveillance/Emerging Infections Program Network. 2002. Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. J. Infect. Dis. 186:118-122.
3. Chen, D., A. McGeer, J. C. de Azavedo, D. E. Low, and the Canadian Bacterial Surveillance Network. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239.
4. Dagan, R. 2000. Clinical significance of resistant organisms in otitis media. Pediatr. Infect. Dis. J. 19:378-382.
5. Empey, P. E., H. R. Jennings, A. C. Thornton, R. P. Rapp, and M. E. Evans. 2001. Levofloxacin failure in a patient with pneumococcal pneumonia. Ann. Pharmacother. 35:687-690.
6. Farrell, D. J., I. Morrissey, S. Bakker, L. Morris, S. Buckridge, and D. Felmingham. 2004. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance. J. Clin. Microbiol. 42:764-768.
7. Fukumi, H., Y. Kaneko, T. Agata, M. Takayanagi, H. Yoshioka, K. Fujita, R. Kawana, K. Shimada, T. Inamatsu, K. Urayama, H. Tanimoto, T. Nakatani, N. Kozakai, T. Oguri, H. Ikemoto, K. Okinaga, M. Kimura, S. Kato, S. Muranaka, S. Uehara, I. Terashima, A. Nakamura, S. Uehara, I. Terashima, A. Nakamura, Y. Nishimura, M. Yamamoto, R. Mikami, M. Sawaki, O. Harikane, H. Hashimoto, K. Matsumoto, H. Suzuki, K. Hara, K. Yamaguchi, M. Matsuse, T. Kishaba, M. Fujihara, I., Tanabe, T. Morigaki, and Y. Togo. 1984. Studies on the clinical application of pneumococcal vaccine. Distribution of Streptococcus pneumoniae in Japan. Kansenshogaku Zasshi 58:39-53. (In Japanese.)
8. Gay, K., W. Baughman, Y. Miller, D. Jackson, C. G. Whitney, A. Schuchat, M. M. Farley, F. Tenover, and D. S. Stephens. 2000. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J. Infect. Dis. 182:1417-1424.
9. Hansman, D., and M. M. Bullen. 1967. A resistant pneumococcus. Lancet ii:264-265.
10. Hausdorff, W., J. Bryant, C. Kloek, P. Paradiso, and G. Siber. 2000. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin. Infect. Dis. 30:122-140.
11. Hofmann, J., M. S. Cetron, M. M. Farley, W. S. Baughman, R. R. Facklam, J. A. Elliott, K. D. Deaver, and R. F. Breiman. 1995. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333:481-486.
12. Hoshino, K., H. Watanabe, R. Sugita, N. Asoh, S. A. Ntabaguzi, K. Watanabe, K. Oishi, and T. Nagatake. 2002. High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children. J. Clin. Microbiol. 40:4357-4359.
13. Ip, M., D. J. Lyon, R. W. H. Yung, C. Chan, and A. F. B. Cheng. 2001. Macrolide resistance in Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 45:1578-1580.
14. Jacobs, M. R., D. Felmingham, P. C. Appelbaum, R. N. Gruneberg, and the Alexander Project Group. 2003. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52:229-246.
15. Jacobs, M. R., H. J. Koornhof, R. M. Robins-Browne, C. M. Stevenson, Z. A. Vermaak, I. Freiman, G. B. Miller, M. A. Witcomb, M. Isaacson, J. I. Ward, and R. Austrian. 1978. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299:735-740.
16. Konno, M., and K. Ubukata (eds.). 1999. Penicillin resistant Streptococcus pneumoniae. Kyowa Kikaku Tushin, Tokyo, Japan.
17. Louie, M., L. Louie, G. Papia, J. Talbot, M. Lovgren, and A. E. Simor. 1999. Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae serotypes in Canada. J. Infect. Dis. 179:892-900.
18. Lynch, J. P., III, and F. J. Martinez. 2002. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin. Infect. Dis. 34(Suppl. 1):S27-S46.
19. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenback, W. Hryniewich, W. Lefévre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
20. Nagata, K., M. Ushijima, N. Yamane, and C. Miyagi. 2003. Hospital-acquired Streptococcus pneumoniae infection. Kansenshogaku Zasshi 77:510-515. (In Japanese.)
21. National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. 11th informational supplement. M100-S11. NCCLS, Wayne, Pa.
22. Nishijima, T., Y. Saito, A. Aoki, M. Toriya, Y. Toyonaga, and R. Fujii. 1999. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. J. Antimicrob. Chemother. 43:637-643.
23. Oguri, T., and N. Kosakai. 1981. Serotypes and drug-susceptibility of Streptococcus pneumoniae isolated from clinical specimens. Jpn. J. Antibiot. 34:95-101. (In Japanese.)
24. Oster, P., A. Zanchi, S. Cresti, M. Lattanzi, F. Montagnani, C. Cellesi, and G. M. Rossolini. 1999. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43:2510-2512.
25. Overweg, K., D. Bogaert, M. Sluijter, J. Yother, J. Dankert, R. De Groot, and P. W. M. Hermans. 2000. Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates. J. Clin. Microbiol. 38:4548-4553.
26. Pfaller, M. A., R. N. Jones, G. V. Doern, H. S. Sader, K. C. Kugler, M. L. Beach, et al. 1999. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 33:283-297.
27. Richter, S. S., K. P. Heilmann, S. L. Coffman, H. K. Huynh, A. B. Brueggemann, M. A. Pfaller, and G. V. Doern. 2002. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin. Infect. Dis. 34:330-339.
28. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 337:970-976.
29. Soares, S., K. G. Kristinsson, J. M. Musser, and A. Tomasz. 1993. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis. 168:158-163.
30. Song, J. H., N. Y. Lee, S. Ichiyama, R. Yoshida, Y. Hirakata, W. Fu, A. Chongthaleong, N. Aswapokee, C. H. Chiu, M. K. Lalitha, K. Thomas, J. Perera, T. T. Yee, F. Jamal, U. C. Warsa, B. X. Vinh, M. R. Jacobs, P. C. Appelbaum, and C. H. Pai. 1999. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin. Infect. Dis. 28:1206-1211.
31. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Ubukata, K., S. Iwata, and K. Sunakawa. 2003. In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. J. Infect Chemother. 9:221-226.
33. Yokota, S.-I., K. Sato, O. Kuwahara, S. Habadera, N. Tsukamoto, H. Ohuchi, H. Akizawa, T. Himi, and N. Fujii. 2002. Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequency in elderly patients in Japan. Antimicrob. Agents Chemother. 46:3311-3315.
34. Yoshida, R., Y. Hirakata, M. Kaku, H. Takemura, H. Tanaka, K. Tomono, H. Koga, S. Kohno, and S. Kamihira. 1997. Trends of genetic relationship of serotype 23 F penicillin-resistant Streptococcus pneumoniae in Japan. Chemotherapy 43:232-238.
35. Yoshida, R., Y. Hirakata, M. Kaku, H. Takemura, H. Tanaka, K. Tomono, H. Koga, S. Kohno, and S. Kamihira. 1997. Genetic relationship of penicillin resistant Streptococcus pneumoniae serotype 19B strains in Japan. Epidemiol. Infect. 118:105-110.